- Home
- MAIA vs NTRB Comparison
MAIA vs NTRB Comparison
Compare MAIA & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- NTRB
- Stock Information
- Founded
- MAIA 2018
- NTRB 2016
- Country
- MAIA United States
- NTRB United States
- Employees
- MAIA N/A
- NTRB N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- MAIA Health Care
- NTRB Health Care
- Exchange
- MAIA Nasdaq
- NTRB Nasdaq
- Market Cap
- MAIA 46.7M
- NTRB 59.1M
- IPO Year
- MAIA 2022
- NTRB N/A
- Fundamental
- Price
- MAIA $2.06
- NTRB $8.20
- Analyst Decision
- MAIA
- NTRB Buy
- Analyst Count
- MAIA 0
- NTRB 1
- Target Price
- MAIA N/A
- NTRB $13.00
- AVG Volume (30 Days)
- MAIA 425.0K
- NTRB 135.0K
- Earning Date
- MAIA 08-08-2025
- NTRB 09-02-2025
- Dividend Yield
- MAIA N/A
- NTRB N/A
- EPS Growth
- MAIA N/A
- NTRB N/A
- EPS
- MAIA N/A
- NTRB N/A
- Revenue
- MAIA N/A
- NTRB $2,398,437.00
- Revenue This Year
- MAIA N/A
- NTRB $560.75
- Revenue Next Year
- MAIA N/A
- NTRB $588.39
- P/E Ratio
- MAIA N/A
- NTRB N/A
- Revenue Growth
- MAIA N/A
- NTRB 18.92
- 52 Week Low
- MAIA $1.40
- NTRB $3.72
- 52 Week High
- MAIA $4.24
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- MAIA 64.26
- NTRB 52.87
- Support Level
- MAIA $1.80
- NTRB $8.01
- Resistance Level
- MAIA $2.03
- NTRB $11.68
- Average True Range (ATR)
- MAIA 0.13
- NTRB 0.69
- MACD
- MAIA 0.03
- NTRB -0.02
- Stochastic Oscillator
- MAIA 93.88
- NTRB 23.86
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.